Cigna Group [CI] stock is trading at $256.38, down -1.23%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CI shares have gain 3.76% over the last week, with a monthly amount drifted -16.42%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cigna Group [NYSE: CI] stock has seen the most recent analyst activity on October 14, 2025, when Goldman initiated its Buy rating and assigned the stock a price target of $370. Previously, Bernstein downgraded its rating to Mkt Perform on February 06, 2025, and kept the price target unchanged to $323. On June 26, 2024, Piper Sandler initiated with a Overweight rating and assigned a price target of $400 on the stock. Robert W. Baird started tracking the stock assigning an Outperform rating and suggested a price target of $388 on May 30, 2024. Barclays initiated its recommendation with a Overweight and recommended $393 as its price target on March 06, 2024. RBC Capital Mkts upgraded its rating to Outperform for this stock on February 05, 2024, and upped its price target to $354. In a note dated February 05, 2024, Cantor Fitzgerald upgraded an Overweight rating on this stock and boosted its target price from $334 to $372.
Cigna Group [CI] stock has fluctuated between $239.51 and $350.00 over the past year. Currently, Wall Street analysts expect the stock to reach $344.63 within the next 12 months. Cigna Group [NYSE: CI] shares were valued at $256.38 at the most recent close of the market. An investor can expect a potential return of 34.42% based on the average CI price forecast.
Analyzing the CI fundamentals
Cigna Group [NYSE:CI] reported sales of 268.22B for the trailing twelve months, which represents a growth of 11.15%. Gross Profit Margin for this corporation currently stands at 0.1% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.03%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.15 and Total Capital is 0.09. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.81.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 253.18 points at the first support level, and at 249.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 262.08, and for the 2nd resistance point, it is at 267.77.
Ratios To Look Out For
For context, Cigna Group’s Current Ratio is 0.83. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 1.63 and price to earnings (TTM) ratio is 11.31.
Transactions by insiders
Recent insider trading involved Cordani David, Chairman & CEO, that happened on Nov 03 ’25 when 4134.0 shares were purchased. Evanko Brian C completed a deal on Oct 03 ’25 to sell 5368.0 shares. Meanwhile, Officer Evanko Brian C bought 5368.0 shares on Oct 03 ’25.
